Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay

Autoimmunity Reviews

Volumn 10, Issue 12, 2011, Pages 801-808

  Op De Beeck, Katrijn ^a   Vermeersch, Pieter ^b   Verschueren, Patrick ^b   Westhovens, René ^b   Mariën, Godelieve ^b   Blockmans, Daniel ^b   Bossuyt, Xavier ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY;

ANTIBODY DETECTION; AUTOIMMUNE DISEASE; BLOOD DONOR; CHRONIC FATIGUE SYNDROME; CONNECTIVE TISSUE DISEASE; HUMAN; IMMUNOFLUORESCENCE; INTERMETHOD COMPARISON; MYOSITIS; PREDICTIVE VALUE; REVIEW; RHEUMATIC DISEASE; SENSITIVITY ANALYSIS; SJOEGREN SYNDROME; SOLID; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; ANTIGENS; AUTOIMMUNE DISEASES; CONNECTIVE TISSUE DISEASES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 80053274380     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.06.005     Document Type: Review

References (27)

1. Doria A., Zen M., Canova M., Bettio S., Bassi N., Nalotto L., et al. SLE diagnosis and treatment: when early is early. Autoimmun Rev 2010, 10:55-60.
2. Solomon D.H., Kavanaugh A.J., Schur P.H. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 2002, 47:434-444. American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines.
3. Bizzaro N., Wiik A. Appropriateness in anti-nuclear antibody testing: from clinical request to strategic laboratory practice. Clin Exp Rheumatol 2004, 22:349-355.
4. Rigon A., Buzzulini F., Soda P., Onofri L., Arcarese L., Iannello G., et al. Novel opportunities in automated classification of antinuclear antibodies on HEp-2 cells. Autoimmun Rev 2011, [Epub ahead of print].
5. Bossuyt X., Hendrickx A., Frans J. Antinuclear antibody titer and antibodies to extractable nuclear antigens. Arthritis Rheum 2005, 53:987-988.
6. Bizzaro N., Tozzoli R., Tonutti E., Piazza A., Manoni F., Ghirardello A., et al. Variability between methods to determine ANA, anti-dsDNA and anti-ENA autoantibodies: a collaborative study with the biomedical industry. J Immunol Methods 1998, 219:99-107.
7. Meroni P.L., Schur P.H. ANA screening: an old test with new recommendations. Ann Rheum Dis 2010, 69:1420-1422.
8. Fenger M., Wiik A., Høier-Madsen M., Lykkegaard J.J., Rozenfeld T., Hansen M.S., et al. Detectiö of antinuclear antibodies by solid-phase immunoassays and immunofluorescence analysis. Clin Chem 2004, 50:2141-2147.
9. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558.
10. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40:1725.
11. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980, 23:581-590.
12. Bohan A., Peter J.B., Bowman R.L., Pearson C.M. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977, 56:255-286.
13. Alarcón-Segovia D., Cardiel M.H. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 1989, 16:328-334.
14. Bossuyt X., Frans J., Hendrickx A., Godefridis G., Westhovens R., Mariën G. Detection of anti-SSA antibodies by indirect immunofluorescence. Clin Chem 2004, 50:2361-2369.
15. Brouwer R., Hengstman G.J., Vree Egberts W., Ehrfeld H., Bozic B., Ghirardello A., et al. Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 2001, 60:116-123.
16. Kroshinsky D., Stone J.H., Bloch D.B., Sepehr A. Case records of the Massachusetts General Hospital. Case 5-2009. A 47-year-old woman with a rash and numbness and pain in the legs. N Engl J Med 2009, 360:711-720.
17. Peene I., Meheus L., Veys E.M., De Keyser F. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing. Ann Rheum Dis 2001, 60:1131-1136.
18. Bossuyt X., Luyckx A. Antibodies to extractable nuclear antigens in antinuclear antibody-negative samples. Clin Chem 2005, 51:2426-2427.
19. Bossuyt X., Mariën G., Vanderschueren S. A 67-year-old woman with a systemic inflammatory syndrome and sicca. Clin Chem 2010, 56:1508-1509.
20. Van den Bergh K., Hooijkaas H., Blockmans D., Westhovens R., Op De Beéck K., Verschueren P., et al. Heterogeneous nuclear ribonucleoprotein h1, a novel nuclear autoantigen. Clin Chem 2009, 55:946-954.
21. Bossuyt X. Clinical performance characteristics of a laboratory test. A practical approach in the autoimmune laboratory. Autoimmun Rev 2009, 8:543-548.
22. Parker J.C., Bunn C.C. Sensitivity of the Phadia EliA connective tissue disease screen for less common disease-specific autoantibodies. J Clin Pathol 2011, 64:631-633.
23. de Macedo P.A., Borba E.F., Viana Vdos S., Leon E.P., Testagrossa Lde A., Barros R.T., et al. Antibodies to ribosomal P proteins in lupus nephritis: a surrogate marker for a better renal survival?. Autoimmun Rev 2011, 10:126-130.
24. Quintana G., Coral-Alvarado P., Aroca G., Patarroyo P.M., Chalem P., Iglesias-Gamarra A., et al. Single anti-P ribosomal antibodies are not associated with lupus nephritis in patients suffering from active systemic lupus erythematosus. Autoimmun Rev 2010, 9:750-755.
25. Mahler M., Silverman E.D., Schulte-Pelkum J., Fritzler M.J. Anti-Scl-70 (topo-I) antibodies in SLE: Myth or reality?. Autoimmun Rev 2010, 9:756-760.
26. Maes L., Blockmans D., Verschueren P., Westhovens R., De Beéck K.O., Vermeersch P., et al. Anti-PM/Scl-100 and anti-RNA-polymerase III antibodies in scleroderma. Clin Chim Acta 2010, 411:965-971.
27. Targoff I.N. Myositis specific autoantibodies. Curr Rheumatol Rep 2006, 8:196-203.